Nanocarrier– tag –
-
AI and Advanced Pharma Tech Converge: Insilico’s INS018_055 Achieves Clinical Success
MDPI Switzerland Overview Artificial intelligence and machine learning are revolutionizing pharmaceutical R&D by integrating with advanced technologies like pharmacogenomics and organ-on-a-chip systems. AI-designed drugs, such as Ins... -
Clinical Landscape of Targeted Protein Degradation Explored, Molecular Glues Show Faster Progress with Nanomedicine Delivery Strategies
MDPI Unknown Overview A new review analyzes the clinical landscape of targeted protein degradation (TPD), focusing on PROTACs and molecular glue degraders, noting that the smaller molecular size of molecular glues may enable faster clini... -
Nanotechnology Overcomes Drug Delivery Challenges: Liposomes & Polymeric Nanoparticles Enhance Drug Solubility and Targeted Delivery
Scientific Review Unknown Overview A recent review highlights nanotechnology's transformative role in overcoming traditional drug delivery challenges, such as poor solubility and non-specific distribution. Diverse nanocarriers, including... -
AAV Capsid-Based Nanocarriers Enable Targeted Delivery of Gold Nanoparticles and Quantum Dots with Enhanced Homogeneity
The Royal Society of Chemistry UK Overview Researchers have developed novel adeno-associated virus (AAV) capsid-based nanocarriers (VPNCs) to overcome limitations of existing nanoparticle delivery systems in biomedical applications. This... -
Nanotechnology Reignites Biotech: Revolutionizing Drug Delivery, Diagnostics, and Cancer Therapy
Facebook Post Unknown Overview The biotechnology sector is experiencing a significant resurgence, driven by transformative technologies such as nanotechnology. Nanoparticles and nanocarriers are proving indispensable for targeted drug de... -
Novel Mesoporous Silica Nanoparticle (MSN)-Based Nanocarrier Targets Non-Small Cell Lung Cancer (NSCLC)
Regeneron ISEF (International Science and Engineering Fair) USA Overview A Regeneron ISEF project unveils a targeted drug delivery nanocarrier for non-small cell lung cancer (NSCLC). This system utilizes doxorubicin hydrochloride (Dox-HC... -
Nanotechnology Revolutionizes Cancer Treatment: EPR Effect Enables Tumor-Selective Drug Delivery and Reduced Toxicity
HCG Oncology India Overview Nanotechnology is revolutionizing cancer treatment by delivering therapeutic drug doses to tumors while minimizing collateral damage to healthy tissue. Nano-drugs, engineered within nanocarrier platforms like ... -
Nanomedicine Revolutionizes Epilepsy Treatment by Enhancing Blood-Brain Barrier Permeation, Targeting Neuroinflammation and Gut-Brain Axis, and Innovating Seizure Prediction and Suppression with Theranostics
PubMed (Journal of Controlled Release) International Overview Nanomedicine is being re-engineered as a novel strategy to overcome the limitations of conventional pharmacotherapy for intractable epilepsy, which is characterized by unpredi... -
Bioengineering Approaches in Nanomedicine Delivery for Myocardial Infarction Overcome Challenges in Targeting and Biocompatibility
American Heart Association Journals USA Overview Nanomedicine, utilizing synthetic nanoparticles and extracellular vesicles as primary delivery platforms, is emerging as a promising strategy for cardiovascular disease therapy, including ... -
Dove Medical Press Reviews Exosome-Inspired Nanocarriers: Next-Gen Drug Delivery for Cancer Therapy
Dove Medical Press UK Overview Dove Medical Press published a review on exosomes as next-generation bio-derived drug delivery systems for cancer therapy. The review emphasizes exosomes' natural ability to cross biological barriers and th...
12